Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

Details for Australian Patent Application No. 2010283748 (hide)

Owner Novartis AG

Inventors Thakur, Jeewan; Yang, Dong; Feng, Lili

Agent Davies Collison Cave

Pub. Number AU-A-2010283748

PCT Pub. Number WO2011/018474

Priority 61/274,051 12.08.09 US

Filing date 11 August 2010

Wipo publication date 17 February 2011

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/018474 Priority application(s): WO2011/018474

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010283753-Absorbent composition and process for removing CO2 and/or H2S from a gas comprising CO2 and /or H2S

2010283742-UTP for the diagnosis of stenoses and other conditions of restricted blood flow